Abdulhamid Sani Usman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdulhamid Sani Usman has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Che Mohd Nasril Che Mohd Nassir
Department of Anatomy and Physiology, Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia
3 shared publications - Hafizah Abdul Hamid
Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
3 shared publications - Mohamad Aris Mohd Moklas
Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia
3 shared publications - Muhammad Zulfadli Mehat
Universiti Putra Malaysia
3 shared publications - Sushmitaa Dhevii Manoharan
Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia
3 shared publications - Anwar Norazit
Department of Biomedical Science, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia
2 shared publications
Latest Publications
- 30 March 2026
- Published by Elsevier in Behavioural Brain Research
- Vol. 507, 116197
Ficus deltoidea attenuates tau hyperphosphorylation and neurodegeneration in a -galactose and aluminum-induced Alzheimer’s disease-like rat model
- 30 March 2026
- Published by Elsevier in Behavioural Brain Research
- Vol. 507, 116197
Ficus deltoidea attenuates tau hyperphosphorylation and neurodegeneration in a -galactose and aluminum-induced Alzheimer’s disease-like rat model
- Open Access
- 20 February 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (2) , 81
Neuroprotective Mechanisms of Ficus deltoidea in an Alzheimer’s Disease-Like Rat Model: Targeting Tau Hyperphosphorylation Through Glycogen Synthase Kinase-3 Beta and Protein Phosphatase 2A Regulation
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by memory loss, neurodegeneration, amyloid plaque accumulation and tau hyperphosphorylation. Dysregulation of glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2 A (PP2A) plays a pivotal role in tau pathology, contributing to synaptic dysfunction and memory impairment. Current AD medications offer limited palliative care, underscoring the need for multifaceted therapeutic strategies. Ficus deltoidea (FD), a medicinal plant renowned for its antioxidant and anti-inflammatory properties, has demonstrated neuroprotective effects, however, its specific role in modulating tau-associated proteins in AD remains underexplored. Thus, this study investigated the neuroprotective properties of FD on the spatial learning and memory, hippocampal histology and the levels of GSK-3β and PP2A in an AD-like rat model. Male rats were administered D-galactose (60 mg/kg) and aluminum chloride (200 mg/kg) for 11 weeks to induce AD-like characteristics. Rats were divided into six groups: control, AD model, donepezil-treated (1 mg/kg), and FD-treated groups receiving 50, 100 and 200 mg/kg of FD extract. Behavioural performances were assessed using the open field test (OFT) and modified elevated plus maze (mEPM). FD administration significantly improved spatial learning and memory in AD-like rats. Nissl staining revealed an increase in viable hippocampal granule neurons in FD-treated rats. Immunoblot analysis reported a reduction in GSK-3β and an increase in PP2A levels, suggesting reduced hippocampal tau phosphorylation. These findings indicate that FD confers neuroprotection by restoring the kinase-phosphatase balance, which in turn enhances hippocampal neuronal survival and memory, thereby supporting its potential as a phytotherapeutic agent for AD intervention.
- 20 February 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (2) , 81
Open AccessNeuroprotective Mechanisms of Ficus deltoidea in an Alzheimer’s Disease-Like Rat Model: Targeting Tau Hyperphosphorylation Through Glycogen Synthase Kinase-3 Beta and Protein Phosphatase 2A Regulation
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by memory loss, neurodegeneration, amyloid plaque accumulation and tau hyperphosphorylation. Dysregulation of glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2 A (PP2A) plays a pivotal role in tau pathology, contributing to synaptic dysfunction and memory impairment. Current AD medications offer limited palliative care, underscoring the need for multifaceted therapeutic strategies. Ficus deltoidea (FD), a medicinal plant renowned for its antioxidant and anti-inflammatory properties, has demonstrated neuroprotective effects, however, its specific role in modulating tau-associated proteins in AD remains underexplored. Thus, this study investigated the neuroprotective properties of FD on the spatial learning and memory, hippocampal histology and the levels of GSK-3β and PP2A in an AD-like rat model. Male rats were administered D-galactose (60 mg/kg) and aluminum chloride (200 mg/kg) for 11 weeks to induce AD-like characteristics. Rats were divided into six groups: control, AD model, donepezil-treated (1 mg/kg), and FD-treated groups receiving 50, 100 and 200 mg/kg of FD extract. Behavioural performances were assessed using the open field test (OFT) and modified elevated plus maze (mEPM). FD administration significantly improved spatial learning and memory in AD-like rats. Nissl staining revealed an increase in viable hippocampal granule neurons in FD-treated rats. Immunoblot analysis reported a reduction in GSK-3β and an increase in PP2A levels, suggesting reduced hippocampal tau phosphorylation. These findings indicate that FD confers neuroprotection by restoring the kinase-phosphatase balance, which in turn enhances hippocampal neuronal survival and memory, thereby supporting its potential as a phytotherapeutic agent for AD intervention.
- 6 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 345
Neuroprotective Effects of Ficus deltoidea in Alzheimer’s Disease-Like Rat Model: Insights from Behavior, Histology, and Amyloid Pathology
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory impairment, and accumulation of amyloid-β (Aβ) plaques. While current treatments offer limited efficacy, medicinal plants such as Ficus deltoidea (FD), a traditional remedy, have shown promise due to their neuroprotective and anti-inflammatory properties. An AD-like phenotype was induced in male Wistar rats using D-galactose and aluminum chloride over 70 days. FD extract was administered orally at 50, 100, and 200 mg/kg. Spatial memory was evaluated using the T-maze test. Histological analyses of the hippocampi’s Cornu Ammonis 1 and 3 (CA1 and CA3) regions were conducted via hematoxylin and eosin (H&E) staining, and Aβ plaques deposition was assessed with Congo red. Enzyme-linked immunosorbent assay (ELISA) was used to quantify hippocampal levels of Aβ (1–42) and β-secretase-1 (BACE-1). FD treatment significantly enhanced spatial memory, preserved pyramidal neuron integrity in CA1 and CA3, and reduced amyloid plaque formation. Biochemically, FD markedly decreased hippocampal Aβ (1–42) and BACE-1 concentrations in a dose-dependent manner. Thus, FD exhibits multi-target neuroprotective effects in an AD-like model, potentially via modulation of amyloidogenic pathways. Further studies are warranted to explore its mechanisms and therapeutic potential in other brain regions implicated in AD.
- 6 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 345
Neuroprotective Effects of Ficus deltoidea in Alzheimer’s Disease-Like Rat Model: Insights from Behavior, Histology, and Amyloid Pathology
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory impairment, and accumulation of amyloid-β (Aβ) plaques. While current treatments offer limited efficacy, medicinal plants such as Ficus deltoidea (FD), a traditional remedy, have shown promise due to their neuroprotective and anti-inflammatory properties. An AD-like phenotype was induced in male Wistar rats using D-galactose and aluminum chloride over 70 days. FD extract was administered orally at 50, 100, and 200 mg/kg. Spatial memory was evaluated using the T-maze test. Histological analyses of the hippocampi’s Cornu Ammonis 1 and 3 (CA1 and CA3) regions were conducted via hematoxylin and eosin (H&E) staining, and Aβ plaques deposition was assessed with Congo red. Enzyme-linked immunosorbent assay (ELISA) was used to quantify hippocampal levels of Aβ (1–42) and β-secretase-1 (BACE-1). FD treatment significantly enhanced spatial memory, preserved pyramidal neuron integrity in CA1 and CA3, and reduced amyloid plaque formation. Biochemically, FD markedly decreased hippocampal Aβ (1–42) and BACE-1 concentrations in a dose-dependent manner. Thus, FD exhibits multi-target neuroprotective effects in an AD-like model, potentially via modulation of amyloidogenic pathways. Further studies are warranted to explore its mechanisms and therapeutic potential in other brain regions implicated in AD.